Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody ADG126 at Upcoming Society for Immunotherapy of Cancer 38th Annual Meeting
| ADAG Stock | USD 2.34 0.03 1.30% |
Roughly 50% of Adagene's stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Adagene suggests that some traders are interested. The current market sentiment, together with Adagene's historical and current headlines, can help investors time the market. In addition, many technical investors use Adagene stock news signals to limit their universe of possible portfolio assets.
Adagene |
- Data reinforces mechanism of action and selection of 10 mgkg every three weeks repeat dosing regimen with pembrolizumab in ongoing MSS CRC dose...
Read at globenewswire.com
 |
Adagene Fundamental Analysis
We analyze Adagene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adagene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adagene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Adagene is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Adagene Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Adagene stock to make a market-neutral strategy. Peer analysis of Adagene could also be used in its relative valuation, which is a method of valuing Adagene by comparing valuation metrics with similar companies.
Peers
Adagene Related Equities
| ANTX | AN2 Therapeutics | 21.90 | ||||
| PMVP | Pmv Pharmaceuticals | 1.25 | ||||
| RZLT | Rezolute | 1.00 | ||||
| ACRV | Acrivon Therapeutics, | 0.80 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.70 | ||||
| MOLN | Molecular Partners | 0.17 | ||||
| AVTE | Aerovate Therapeutics | 0.38 | ||||
| ANAB | AnaptysBio | 0.64 | ||||
| ELYM | Eliem Therapeutics | 1.30 | ||||
| JANX | Janux Therapeutics | 2.54 | ||||
| MLYS | Mineralys Therapeutics, | 2.59 |
Complementary Tools for Adagene Stock analysis
When running Adagene's price analysis, check to measure Adagene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adagene is operating at the current time. Most of Adagene's value examination focuses on studying past and present price action to predict the probability of Adagene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adagene's price. Additionally, you may evaluate how the addition of Adagene to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |